Permeation Efficacy of a Transdermal Vehicle with Steroidal Hormones and Nonsteroidal Anti-inflammatory Agents as Model Drugs
-
Published:2018-12-14
Issue:2
Volume:16
Page:136-141
-
ISSN:1567-2018
-
Container-title:Current Drug Delivery
-
language:en
-
Short-container-title:CDD
Author:
Junqueira Laura A.1, Polonini Hudson2, Loures Sharlene2, Raposo Nádia R.B.1, Ferreira Anderson O.1, Brandão Marcos Antônio F.2
Affiliation:
1. NUPICS- Nucleo de Pesquisa e Inovacao em Ciencias da Saude, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil 2. Ortofarma Laboratory, Matias Barbosa, Brazil
Abstract
Background:
Transdermal delivery is an alternative route for the administration of drugs.
However, it requires the development of vehicles that allow the drugs to cross the layers of the skin and
reach the systemic circulation.
Objective:
In this study, a new transdermal vehicle was evaluated using progesterone, estradiol, estradiol
+ estriol (Biest) and ketoprofen administered as model drugs.
</P><P>
Methods: To evaluate the ex vivo permeation of the drugs, the Franz vertical diffusion cell with human
skin was used.
Results:
After 24 h, the vehicle was able to deliver 18.32 µg/cm2 of progesterone and 92.07 µg/cm2 of
ketoprofen through the skin to the receptor medium. The permeation percentages were 91%, 78.8%,
48.5%, 73.2%, and 63.6%, respectively, for estradiol, estradiol (Biest), estriol (Biest), progesterone and
ketoprofen. For all drugs, sufficient amounts were delivered to achieve a systemic effect, and it was
also possible to decrease the amount of emulsion applied.
Thus, the vehicle demonstrated a high performance and the possibility of it being used for
drugs that present difficulties in regards to administration by the transdermal route.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science
Reference43 articles.
1. Cobo A, Sheybani R, Meng E. Adv Healthc Mater, MEMS: Enabled drug delivery systems.,, 2015, 4,, 969-982, 2. Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee SK. Int J Pharm Investig, Drug delivery systems: An updated review.,, 2012, 2,, 2-11, 3. Mathias NR, Hussain MA. J Pharm Sci, Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration.,, 2010, 99,, 1-20, 4. Ye D, Zhang X, Yue Y, Raliya R, Biswas P, Taylor S, Tai YC, Rubin JB, Liu Y, Chen H. J Control Release, Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain.,, 2018, 286,, 145-153, 5. Robinson A, Wermeling DP. Am J Health Syst Pharm, Intranasal naloxone administration for treatment of opioid overdose.,, 2014, 71,, 2129-2135,
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|